PureTech Health (PRTC) Total Liabilities (2019 - 2025)
PureTech Health (PRTC) reported Total Liabilities of $229.0 million for Q4 2025, up 17.63% year-over-year from $194.7 million in Q4 2024, and up 24.33% quarter-over-quarter from $184.2 million in Q2 2025.
PureTech Health (PRTC) Total Liabilities (2019 - 2025) Analysis & Trends
PureTech Health (PRTC) has 7 years of Total Liabilities data on file, last reported at $229.0 million in Q4 2025.
- Total Liabilities for Q4 2025 came in at $229.0 million, up 17.63% year-over-year; the trailing twelve-month figure through Dec 2025 was $229.0 million (up 17.63% YoY), and the FY2025 annual result was $229.0 million, up 17.63% from the prior year.
- Total Liabilities rose to $229.0 million in Q4 2025 per PRTC's latest filing, from $184.2 million in the prior quarter.
- Over five years, Total Liabilities peaked at $361.9 million in Q4 2021 and troughed at $155.1 million in Q4 2022.
- A 5-year average of $233.5 million and a median of $229.0 million in 2025 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities tumbled 57.15% in 2022, then soared 52.04% in 2023.
- A 5-year view of Total Liabilities shows it stood at $361.9 million in 2021, then plunged by 57.15% to $155.1 million in 2022, then surged by 52.04% to $235.7 million in 2023, then decreased by 17.41% to $194.7 million in 2024, then climbed by 17.63% to $229.0 million in 2025.
- Business Quant data shows PRTC's Total Liabilities at $229.0 million in Q4 2025, $184.2 million in Q2 2025, and $194.7 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 229.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 229.03 Mn |
| Jun 30, 2025 | 184.22 Mn |
| Dec 31, 2024 | 194.70 Mn |
| Jun 30, 2024 | 273.74 Mn |
| Dec 31, 2023 | 235.74 Mn |
| Dec 31, 2022 | 155.06 Mn |
| Dec 31, 2021 | 361.86 Mn |
| Dec 31, 2020 | 336.46 Mn |
| Dec 31, 2019 | 290.78 Mn |